MRD / Regn No. : SG004147 Date : 22/07/2026
Patient Name : C Mehta Age & Gender : 66 Yrs. / Female
Contact No. : 9830661857 UHID :
Ht / Wt / BMI : 155 / 101 / 42.04 BP S / BP D : 116 / 70
Allergies : NKA Referred By :
   
Problem List : OBESITY (05/Feb/2026) | HYPERTENSION (05/Feb/2026) | TYPE 2 DIABETES (05/Feb/2016) | HYPOTHYROIDISM (05/Feb/2026) |
Salient Investigations : CREATININE: 0.85 | EGFR EGLOMERULAR FILTRATION RATE: 71.57 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 74 mg/dL | HB HEMOGLOBIN: 11.5 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7 % | LDL LOW DENSITY LIPOPROTEIN: 48 mg/dL | TSH THYROID STIMULATING HORMONE: 3.76 mIU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET THYROXINE 25 MCG
THYRONORM 25 MCG
Medicine For LOW THYROID
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
MUST BE TAKEN ON AN EMPTY STOMACH. COFFEE TEA OR BREAKFAST MUST BE TAKEN ONLY AFTER 30 MINUTES. OTHER DRUGS CAN INTERFERE WITH THE ABSORPTION OF THYROXINE
2 ROSUVASTATIN 10 MG
ROSAVEL
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
3 CLONAZEPAM 0.5
ZAPIZ
PO 0-0-1 BEFORE FOOD
TILL NEXT VISIT
4 PREGABALIN 75 MG + NORTRYPTYLINE 10 MG
PREGEB NT 75/10 MG
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
5 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + METFORMIN 1000 SR
APDA M FORTE
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
6 ANTIHYPERGLYCEMIC GLICLAZIDE XR 60 MG
SECGLY XR 60 MG
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
7 TABLET TELMISARTAN 40 MG
APEL 40
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
8 ANTIHYPERGLYCEMIC SEMAGLUTIDE 2.4 MG
NOVELTREAT 2.4 MG
SC ONCE A WEEK AFTER BREAKFAST
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 22/Oct/2026
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,LDL-C,ECG (ALL LEADS),UACR:SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: